Precision Medicine and Health Consortium (PMHC)

The Precision Medicine and Health Consortium capitalizes on the expertise within the scientific community, health systems, payor industry and others to make novel discoveries and therapeutic advances in precision medicine, and translate these to improve healthcare. 

The PMHC joins together faculty with a common purpose and connects faculty with expertise in precision medicine to address health problems using an interdisciplinary approach. It is our belief that a interdisciplinary group will more quickly advance research, educational, and outreach activities.

Members of the PMHC also bridge the gap between genetic research discoveries and application in patient care. Precision Medicine is a national priority and this group strives to keep on the forefront of this evolving field.

Latest News

Initial Protocol Released for "All of Us" Research Program

The NIH released the initial research protocol for the All of Us Research Program. Read the full announcement and the frequently asked questions releases.  

Seminar: Working Together on Pharmacogenetics: Report on a Tribal-University Partnership

Wylie BurkeWylie Burke, M.D., Ph.D.

Wednesday, April 12, 2017
"Working Together on Pharmacogenetics: Report on a Tribal-University Partnership"

The Precision Medicine and Health Disparities Summit

DNAThe Precision Medicine and Health Disparities Summit was held on Monday, March 27, 2017 at the University of Minnesota Medical School in Duluth.  See the recording of the event (x500 required).

Fairview Health Services: Can Genetic Tests Improve High Blood Pressure Care?

High blood pressureFairview Health Services is working with a local genetics research firm to determine if DNA tests can steer patients to more effective treatment for high blood pressure.

U-PGx: Treatment Optimization Accessible to Every European Citizen

U-PGx logoA new project titled "U-PGx" aims to make effective treatment optimization accessible to every European citizen. The U-PGx consortium will examine whether pre-emptive genotyping of an entire panel of genetic markers is cost-effective and results in a better outcome for patients.

CPIC Guideline Videos Available

CPIC logoA new resource is available on PharmGKB to help researchers and clinicians more easily and quickly understand CPIC recommendations and how to find supporting information on the PharmGKB website.

Exceptional Response’ to First-Line Vismodegib Reported in Patient With Unresectable/Multifocal Adult Medulloblastoma

brainThe ASCO Post highlighted the extraordinary response to targeted therapy of a patient with an adult medulloblastoma brain tumor, the first such report in the first-line setting using hedgehog inhibitor vismodegib (Erivedge).  The case report was published in 

U of M Grand Challenge Collaboration Research Grant Awarded to Precision Medicine

DNA strands"Minnesota Precision Medicine Collaborative: Transforming health and advancing equity," was named one of eight U of M Grand Challenges Research collaboration grants to advance the research goals of the TC Campus Strategic Plan over the next ten years.

U of M Grand Challenges Exploratory Research Grants Awarded to Precision Medicine

dessertDevelopment of a clinical precision medicine program in ovarian cancer as a paradigm for 21st century tailored health care solutions 

Pages

Upcoming Seminars

Presented by The Minnesota Precision Medicine Collaborative

2:00-3:00 p.m.
5-125 Moos Tower (Duluth via ITV - TBA)

September 1, 2017
Recent and Ongoing Work in Precision Medicine within the VA Health Care System
Eric W. Dieperink, MD—Veterans Affairs Medical Center

October 6, 2017
Health Informatics to Facilitate Precision Medicine
Rui Zhang, PhD—Assistant Professor, Department of Pharmaceutical Care & Health Systems and Institute for Health Informatics, University of Minnesota

November 3, 2017
Making Complex Cancer Genomics Data Accessible and Interpretable
Nikolaus Schultz, PhD—Head of Knowledge Systems, Marie-Josée & Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center

December 1, 2017
Implementation of Clinical Pharmacogenomics at Children’s Minnesota
David Gregornik, PharmD, BCOP—Pharmacogenomics Program Leader, Children’s Minnesota

 

Save the Date

Pharmacogenomics Conference 2018
Genomic Testing to Individualize Drug Therapy
Friday, June 22, 2018 8am-5pm
McNamara Alumni Center
University of Minnesota, Minneapolis, MN

Join our Google Group

Join our Google Group to receive Precision Medicine and Health Consortium communications.

21st Century Cures Initiative Passed

Congress passed the 21st Century Cures Initiative, a $6.3 billion medical research bill. The bill authorizes significant funding for various health care related programs over the next 10 years, including $1.5 billion for Obama's Precision Medicine Initiative.

Links

2016 Precision Medicine Conference presentation videos

Genomics and Health Impact Weekly Scan  This weekly update features emerging roles of human genomics, testing and interventions in a wide variety of noncommunicable diseases across the life span.

Contact Us

Pamala Jacobson, PharmD
pmhconso@umn.edu